Nevertheless, another study showed no significant difference in brain RT response among NSCLC patients with and without EGFR mutations (67% vs. 50%; p = 0.23) by assessing at least 1 post-treatment brain MRI scan [18]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.